New vaginal yeast infection treatment enters phase 1 trial in US 12-Feb-2024 By Isabel Cameron Sano Chemicals has begun its phase 1, first-in-human clinical trial of Occidiofungin, a new treatment to cure recurrent vaginal yeast infections or vulvovaginal candidiasis (RVVC).